Chronic Electronic Cigarette Exposure Promotes Atherosclerosis and Chondrogenic Modulation of Smooth Muscle Cells

Chronic electronic cigarette exposure accelerates atherosclerosis by driving smooth muscle cells toward a pro-calcifying, chondrogenic phenotype via a GRIN2A-dependent glutamatergic/NMDAR signaling pathway, which can be reversed by inhibiting this specific molecular axis.

The Gist

The Big Picture: Vaping Isn't Just "Harmless Water Vapor"

You might have heard that electronic cigarettes (e-cigs) are a safer alternative to traditional smoking. While they might have fewer cancer-causing chemicals, this new study from Stanford University suggests they are still doing serious damage to your heart and blood vessels.

Think of your blood vessels (arteries) like a highway system. The smooth muscle cells (SMCs) are the construction crew and road maintenance workers that keep the highway smooth, flexible, and strong.

This study found that breathing in e-cigarette aerosol is like throwing a wrench into the construction crew's machinery. It doesn't just clog the road (plaque); it actually brainwashes the construction workers into building something completely wrong, turning flexible roads into brittle, rocky terrain.

---

The Experiment: A Mouse Model of the Heart

The researchers used a special type of mouse that gets heart disease easily (because of high cholesterol) and has a "glow-in-the-dark" tag on its construction workers (smooth muscle cells).

They split the mice into two groups:

1. Control Group: Breathed filtered, clean air.
2. E-Cig Group: Breathed e-cigarette vapor (specifically Juul Virginia Tobacco flavor) for several months.

The Result: The mice breathing the e-cig vapor developed much worse heart disease. Their "roads" were more clogged, and they had more inflammation. Crucially, this happened even though their blood cholesterol levels were the same as the clean-air mice. This proves the damage comes directly from the vapor, not just from eating bad food.

---

The Twist: The Construction Crew Gets Confused

Here is the most surprising part of the discovery.

Normally, when a blood vessel gets injured, the smooth muscle cells (the workers) change shape to help heal it. But under the influence of e-cigarette vapor, these cells didn't just change; they completely forgot who they were.

• The Analogy: Imagine a team of bricklayers (smooth muscle cells) who are supposed to build a flexible, rubbery wall to keep the artery open.
• The E-Cig Effect: The vapor hits them, and suddenly, they start acting like stone masons. They stop building rubbery walls and start building hard, brittle stone structures.
• The Science: The cells switched from a "muscle" identity to a "cartilage" (chondrogenic) identity. This is called chondrogenic modulation.

Why does this matter? Cartilage is hard. When your soft, flexible arteries turn into hard, cartilage-like structures, they calcify (turn to bone). This makes the arteries stiff and prone to cracking, which is a major cause of heart attacks and strokes.

---

The "Smoking Gun": A Brain Chemical in the Heart?

How does a puff of vapor turn a muscle cell into a stone-mason cell? The researchers found a very strange mechanism involving a chemical usually found in the brain.

1. The Brain Connection: In your brain, a chemical called Glutamate acts as a messenger. It binds to a receptor called NMDAR (specifically the GRIN2A part) to help you learn and remember things.
2. The Unexpected Discovery: The researchers found that e-cigarette vapor turns on these "brain receptors" inside your heart muscle cells.
3. The Chain Reaction:
   • The vapor causes the heart cells to release more Glutamate.
   • This Glutamate hits the NMDAR receptors on the same cells.
   • This triggers a flood of Calcium into the cells (like a floodgate opening).
   • This calcium flood acts as a "switch," telling the cell: "Stop being a muscle cell. Start building bone/cartilage."

The Proof: When the researchers used a drug to block these brain receptors (NMDAR) in human cells, the e-cigarette vapor could no longer turn the muscle cells into stone-masons. The damage was stopped.

The "Nicotine" Misconception

You might think, "Is it just the nicotine?"
The researchers tested pure nicotine on the cells. It didn't work. Nicotine alone didn't trigger this brain-chemical pathway.

This suggests that the other chemicals in the vapor (like flavorings, aldehydes, or metals) are the real culprits that flip this specific switch. It's not just the "buzz" of nicotine; it's the toxic cocktail of the vapor itself.

---

Summary: What Does This Mean for You?

1. E-Cigs are not harmless: They actively reprogram the cells in your arteries to become hard and brittle, accelerating heart disease.
2. It's a direct attack: This happens even if your diet and cholesterol are perfect. The vapor attacks the vessel wall directly.
3. The Mechanism is weird: E-cigs hijack a "brain chemical" pathway (Glutamate/NMDAR) that shouldn't be active in your heart, causing a calcium flood that turns soft tissue into hard bone.
4. Future Hope: Because they identified this specific "brain receptor" (GRIN2A) as the culprit, doctors might one day be able to develop drugs that block this specific pathway to protect vapers' hearts, or at least prove that stopping vaping reverses this specific damage.

In short: Breathing e-cigarette vapor is like pouring acid on your body's construction crew, convincing them to build a stone wall instead of a flexible road, using a "brain signal" that shouldn't be there.

Technical Summary

1. Problem Statement

Despite the global epidemic of electronic cigarette (E-cig) use, the specific cellular and molecular mechanisms by which chronic E-cig aerosol exposure accelerates atherosclerosis remain poorly defined. While epidemiological data suggests a link between E-cigs and cardiovascular disease (CVD), it is unclear:

• Which specific vascular cell types are most vulnerable to E-cig toxicity.
• How E-cig exposure alters the phenotypic state of vascular smooth muscle cells (SMCs), a critical driver of plaque stability and calcification.
• What novel signaling pathways mediate these pathological changes, particularly given that E-cig aerosols contain complex mixtures of toxicants beyond just nicotine.

2. Methodology

The study employed a multi-omics approach combining in vivo animal models, in vitro human cell models, and advanced single-cell technologies.

• Animal Model:
  • Subjects: Hyperlipidemic ApoE⁻/⁻ mice with an SMC-specific lineage tracing system (Myh11-CreERT2 × Rosa26-tdTomato).
  • Exposure: Mice were exposed to Juul Virginia Tobacco flavor aerosol (5.0% nicotine) via a whole-body chamber (2 hours/day, 3 days/week) for 12–16 weeks on a high-fat diet. Controls received filtered air.
  • Validation: Systemic nicotine delivery was confirmed via urinary cotinine metabolites. Lipid profiles were measured to rule out lipid-mediated mechanisms.
• Single-Cell Multi-Omics:
  • scRNA-seq & scATAC-seq: Aortic tissues were dissociated, and SMC-lineage cells (tdTomato⁺) were sorted. Single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) were performed to profile transcriptomic and epigenomic landscapes.
  • Analysis: Data were analyzed using Seurat and Signac for clustering, differential expression (DE), and transcription factor (TF) motif accessibility.
• In Vitro Human Models:
  • Cells: Primary Human Coronary Artery Smooth Muscle Cells (HCASMCs).
  • Treatment: Exposure to E-cig aerosol extract (non-toxic concentrations).
  • Interventions: siRNA-mediated knockdown and overexpression of GRIN2A (NMDA receptor subunit).
  • Functional Assays: Calcium flux imaging (using NMDA/D-serine stimulation), EdU proliferation assays, calcification assays, and monocyte transwell migration assays.
• Human Tissue Validation:
  • RNAscope in situ hybridization was performed on coronary artery samples from heart transplant recipients with atherosclerosis to localize GRIN2A and glutaminase (GLS1) expression.

3. Key Contributions

• Cell-Type Specific Vulnerability: Identified SMCs as the most transcriptionally and epigenetically responsive vascular cell type to chronic E-cig exposure, surpassing endothelial cells, fibroblasts, and macrophages.
• Novel Phenotypic Shift: Discovered that E-cig exposure drives SMCs toward a chondrogenic, pro-calcifying phenotype (termed "chondromyocytes" or CMCs) rather than a purely inflammatory or synthetic state.
• Mechanistic Discovery: Uncovered a previously unrecognized glutamatergic/NMDAR signaling axis in vascular SMCs as a primary driver of E-cig-induced vascular remodeling.
• Nicotine Independence: Demonstrated that the pathological effects are not solely mediated by nicotine, implicating other aerosol constituents (e.g., aldehydes, flavorings) in the activation of glutamate pathways.

4. Key Results

A. Accelerated Atherosclerosis Independent of Lipids

• Chronic E-cig exposure significantly increased total lesion area and macrophage burden (Cd68⁺) in ApoE⁻/⁻ mice.
• Crucially, these effects occurred independently of systemic lipid levels (cholesterol, triglycerides, LDL/HDL) and intralesional lipid deposition, indicating a direct vascular toxic effect.

B. SMC Chondrogenic Reprogramming

• Transcriptomics: scRNA-seq revealed a massive shift in SMC clusters. E-cig exposure increased the proportion of Chondromyocytes (CMCs) from ~3% (control) to ~30% (E-cig).
• Markers: CMCs were characterized by the upregulation of chondrogenic markers (Col2a1, Sox9, Chad, Ibsp) and downregulation of contractile markers (Acta2, Myh11).
• Phenotype: This shift correlated with increased vascular ossification (alkaline phosphatase activity) and plaque calcification.
• Inflammation: E-cig exposure also expanded a pro-inflammatory SMC subpopulation (FMC2) expressing C3, Cxcl12, and Fbln1, which recruited monocytes in co-culture assays.

C. Epigenetic Activation of Glutamatergic Pathways

• scATAC-seq: Revealed a global increase in chromatin accessibility in SMCs. A distinct cluster of SMCs showed increased accessibility in genes related to synaptic transmission and glutamate receptor signaling.
• Key Target: The NMDA receptor subunit Grin2a (and Grin2b) was identified as a central node, with increased chromatin accessibility and expression specifically at the transition from fibromyocytes (FMC) to chondromyocytes (CMC).
• Transcription Factors: E-cig exposure activated TF motifs for Klf4, Egr1, Mef2, and interferon-responsive factors (IRF8, STAT5), linking epigenetic changes to the phenotypic switch.

D. Functional Validation in Human Cells

• GRIN2A Dependency: In HCASMCs, E-cig extract upregulated GRIN2A. siRNA knockdown of GRIN2A completely abolished E-cig-induced dedifferentiation (reduced LUM, HAPLN1) and calcification. Conversely, GRIN2A overexpression mimicked E-cig effects.
• Calcium Signaling: E-cig exposure increased intracellular Ca²⁺ flux in HCASMCs. This flux was dependent on NMDAR activation (blocked by MK-801) and required co-agonists (D-serine).
• Glutamate Metabolism: E-cig treatment increased extracellular glutamate levels and upregulated enzymes involved in the glutamate-glutamine cycle (GLS1, GLUL, SLC1A3, SLC7A11), suggesting a disruption in glutamate homeostasis.
• Nicotine vs. Aerosol: Treatment with nicotine alone did not induce GRIN2A expression or Ca²⁺ flux, confirming that non-nicotine aerosol components drive this pathway.

E. Human Relevance

• RNAscope in human atherosclerotic plaques confirmed the presence of GRIN2A and GLS1 in the lesion cap and media, validating the translational relevance of the mouse and cell culture findings.

5. Significance and Implications

• Paradigm Shift: This study challenges the view that E-cig cardiovascular risk is primarily driven by nicotine or lipid metabolism. Instead, it highlights a direct, nicotine-independent mechanism involving the reprogramming of SMCs via neurotransmitter signaling pathways.
• Novel Therapeutic Target: The GRIN2A/NMDAR axis is identified as a potential therapeutic target. Pharmacological inhibition of this pathway could mitigate E-cig-induced vascular calcification and atherosclerosis.
• Public Health Impact: The findings provide a molecular basis for regulatory policies, suggesting that E-cigs pose a distinct and severe risk for vascular calcification and plaque vulnerability, independent of traditional smoking risks.
• Biological Insight: It expands the known role of NMDARs beyond the central nervous system, revealing their critical function in vascular plasticity and disease in response to environmental toxicants.

Conclusion: Chronic E-cig exposure drives atherosclerosis by epigenetically reprogramming vascular SMCs into a chondrogenic, calcifying state via a GRIN2A-dependent glutamatergic signaling pathway, a process driven by non-nicotine aerosol constituents.